... San Antonio Breast Cancer Symposium highlighting the activity the ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
News
- Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and ...
- Celcuity's Breast Cancer Drug Shows Breakthrough 77-Month Survival Data in Clinical Trial
The data was presented at the San Antonio Breast Cancer Symposium (SABCS) in December 2024. ... Celcuity is a clinical-stage biotechnology ...
- Authorities say the mystery disease in Congo might be malaria but more testing is needed
... Biomedical Research in Kinshasa, told The Associated Press. ... Officer William Kasberg of the San Antonio Police Department's DWI unit gives a field ...
- Cancer therapy shows long-term survival benefits for patients with high-risk, BRCA-positive ...
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases ... San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024 ...
- Full Getinge Surgical Workflows Portfolio Installed at UT Health San Antonio
UT Health San Antonio's new facility is designed to support a wide range of medical ... biomedical research, manufacturing of medical devices and ...